Child Asthma: Chronic-Dose Safety and Efficacy Study of a Bronchodilator Inhaler in Pediatric Asthmatics: "This study is designed to evaluate the repeat-dose safety and effectiveness of a bronchodilator inhaler relative to placebo (inactive drug inhaler) in children aged 4-11 years with asthma. The dosing period lasts three weeks and starts following a three-week run-in period. "
Saturday, September 23, 2006
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment